SiteOne

Neurosciences

This company develops precision sodium channel therapeutics to treat patients with neurological conditions such as genetic epilepsy and chronic neuropathic pain.

Navion

This biotechnology company develops precision sodium channel medicines for patients with neurological conditions including genetic epilepsy and chronic neuropathic pain.

Attenua

This company develops small-molecule medicines for patients suffering from chronic respiratory disorders, particularly chronic cough.

Saol Therapeutics

This pharmaceutical company develops clinical-stage therapies for patients with central nervous system disorders, pain, spasticity and orphan diseases.

Afferent

This clinical-stage biopharmaceutical company develops small molecule drugs targeting P2X3 receptors to treat patients with chronic cough and other neurogenic disorders.

Latigo Biotherapeutics

This clinical-stage biopharmaceutical company develops non-opioid medicines to treat patients suffering from pain without the risk of addiction.

Brise Pharmaceuticals Co., LTD.

This biopharmaceutical company develops analgesic treatments for patients with severe pain conditions including migraine, neuropathic pain, and musculoskeletal pain.

SiccaNova Therapeutics

This biopharmaceutical company develops small-molecule therapeutics to treat medical conditions involving dryness, including xerostomia and dry eye, for patients with unmet medical needs.